Destiffening effect of valsartan and atenolol: Influence of heart rate and blood pressure

Journal of Hypertension

Volumn 32, Issue 1, 2014, Pages 108-114

  Boutouyrie, Pierre ^a,b,c   Beaussier, Hélène ^b,c,d   Achouba, Assya ^e   Laurent, Stéphane ^a,b,c   Gosse, Philippe ^f   London, Gérard ^f   Pannier, Bruno ^f   Poncelet, Pascal ^f   Lantelme, Pierre ^f   Legedz, Liliana ^f   Fesler, Pierre ^f   Levy, Bernard ^f   Thuillez, Christian ^f   Joannides, Robinson ^f   Stephan, Dominique ^f   Laurent, Pierre ^f   Doll, Gérard ^f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e NOVARTIS PHARMA K K   (Japan)

^f NONE

Author keywords

Arteries; Central pressure; Compliance; Drug treatment; Stiffness

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS ATENOLOL; AMLODIPINE PLUS VALSARTAN; ATENOLOL; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TONOMETRY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; TETRAZOLES; VALINE; VASCULAR STIFFNESS;

EID: 84891556733     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000014     Document Type: Article

References (42)

1. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605
2. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension 2005; 46:200-204
3. Laurent S, Briet M, Boutouyrie P. Large and small artery cross-Talk and recent morbidity-mortality trials in hypertension. Hypertension 2009; 54:388-392
4. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-Analysis. Eur Heart J 2010; 31:1865-1871
5. Asmar RG, London GM, O'Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol. Hypertension 2001; 38:922-926
6. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225
7. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-Atenolol combination: The EXPLOR study. Hypertension 2010; 55:1314-1322
8. Miyashita H, Aizawa A, Hashimoto J, Hirooka Y, Imai Y, Kawano Y, et al. Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. Am J Hypertens 2010; 23:260-268
9. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54:716-723
10. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: Experts' opinion and review of the data. Hypertension 2009; 54:375-383
11. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, et al. Pharmacological modulation of arterial stiffness. Drugs 2011; 71:1689-1701
12. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352:1951-1958
13. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996; 14:897-901
14. Lantelme P, Mestre C, Lievre M, Gressard A, Milon H. Heart rate: An important confounder of pulse wave velocity assessment. Hypertension 2002; 39:1083-1087
15. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-Analysis. Lancet 2005; 366:1545-1553
16. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665
17. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-Analysis. J Am Coll Cardiol 2010; 55:1318-1327
18. Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, et al. Aortic stiffness is reduced beyond blood pressure lowering by shortterm and long-Term antihypertensive treatment: A meta-Analysis of individual data in 294 patients. J Hypertens 2011; 29:1034-1042
19. Reference values for arterial stiffness' collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31:2338-2350
20. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De BT, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448
21. Breslow NE, Clayton DG. Approximate inference in generalized linear mixed models. J Am Stat Assoc 1993; 88:9-25
22. Groenink M, de RA, Mulder BJ, Spaan JA, van der Wall EE. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 1998; 82:203-208
23. Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009; 54:409-413
24. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99
25. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Shimada K, Kario K. Association between aldosterone induced by antihypertensive medication and arterial stiffness reduction: The J-CORE study. Atherosclerosis 2011; 215:184-188
26. Dhakam Z, Yasmin. McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008; 26:351-356
27. Dhakam Z, McEniery CM, Yasmin. Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: Differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006; 19:214-219
28. Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-Term antihypertensive treatment. Circulation 2000; 101:2601-2606
29. Kahonen M, Ylitalo R, Koobi T, Turjanmaa V, Ylitalo P. Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective betablockers on arterial pulse wave velocity in normotensive subjects. Gen Pharmacol 2000; 35:219-224
30. Albaladejo P, Copie X, Boutouyrie P, Laloux B, Declere AD, Smulyan H, et al. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension 2001; 38:949-952
31. Laurent P, Albaladejo P, Blacher J, Rudnichi A, Smulyan H, Safar ME. Heart rate and pulse pressure amplification in hypertensive subjects. Am J Hypertens 2003; 16:363-370
32. Haesler E, Lyon X, Pruvot E, Kappenberger L, Hayoz D. Confounding effects of heart rate on pulse wave velocity in paced patients with a low degree of atherosclerosis. J Hypertens 2004; 22:1317-1322
33. Boutouyrie P, Bezie Y, Lacolley P, Challande P, Chamiot-Clerc P, Benetos A, et al. In vivo/in vitro comparison of rat abdominal aorta wall viscosity. Influence of endothelial function. Arterioscler Thromb Vasc Biol 1997; 17:1346-1355
34. Millasseau SC, Stewart AD, Patel SJ, Redwood SR, Chowienczyk PJ. Evaluation of carotid-femoral pulse wave velocity: Influence of timing algorithm and heart rate. Hypertension 2005; 45:222-226
35. Hermeling E, Reesink KD, Reneman RS, Hoeks AP. Confluence of incident and reflected waves interferes with systolic foot detection of the carotid artery distension waveform. J Hypertens 2008; 26:2374-2380
36. Lehoux S, Castier Y, Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med 2006; 259:381-392
37. Tan I, Butlin M, Liu YY, Ng K, Avolio AP. Heart rate dependence of aortic pulse wave velocity at different arterial pressures in rats. Hypertension 2012; 60:528-533
38. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 2010; 106:1675-1680
39. Ruster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011; 22:1189-1199
40. Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: A meta-Analysis and meta-regression of randomised controlled trials. Atherosclerosis 2011; 221:18-33
41. Tropeano AI, Boutouyrie P, Pannier B, Joannides R, Balkestein E, Katsahian S, et al. Brachial pressure-independent reduction in carotid stiffness after long-Term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48:80-86
42. Ait-Oufella H, Collin C, Bozec E, Laloux B, Ong KT, Dufouil C, et al. Long-Term reduction in aortic stiffness: A 5.3-year follow-up in routine clinical practice. J Hypertens 2010; 28:2336-2341